Abstract
There are two isozymes, prostaglandin endoperoxide synthase-1 and -2 (PGHS-1 and PGHS-2; also referred to as cyclooxygenase-1 and -2; COX-1 and COX-2) which catalyze the conversion of arachidonate to prostaglandin H2 (Smith, W. L. and DeWitt, 1995). These are central enzymes in two separate prostaglandin biosynthetic pathways. PGHS-1, an enzyme constitutively expressed in most tissues and in platelets, is a member of a biosynthetic pathway that responds instantaneously to stimulation by circulating hormones and produces prostaglandins that exit and act via cell surface receptors. The PGHS-1 pathway is also responsible for the production of prostaglandins in platelets and endothelial cells that acutely regulate vascular homeostasis and thrombus formation. PGHS-2, an enzyme which is expressed only in response to inflammatory, mitogenic, or other specialized stimuli, is the center of an inducible biosynthetic pathway that produces prostaglandins mediating specialized physiological responses such as inflammation, mitogenesis, or ovulation. Prostaglandins produced by PGHS-2 act extracellularly, but in addition, may signal within the nucleus. In this review, we will compare the structures, enzymology and regulation of expression of these two enzymes, and we will present evidence that indicates these pathways are physically as well as functionally separated, and likely coupled to different phospholipases or fatty acid substrate pools. The physiological as well as pharmacological significance of these separate system will also be examined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Appleby, S. B., Ristimaki, A., Neilson, K., Narko, K., and Hla, T. (1994). Structure of the human cyclo-oxygenase-2 gene. Biochem. J. 302(15 Sep Pt 3), 723–727.
Barnett, J., Chow, J., Ives, D., Chiou, M., Mackenzie, R., Osen, E., Nguyen, B., Tsing, S., Bach, C., Freire, J., Chan, H., Sigal, E., and Ramesha, C. (1995). Purification, characterization and selective inhibiton of human prostaglandin G/H 1 and 2 expressed in the baculovirus system. Bioch. Biophys. Acta in press.
Bhattacharyya, D. K., Lecomte, M., Dunn, J., Morgans, D. J., and Smith, W. L. (1995). Selective inhibiton of prostaglandin endoperoxide synthase-1 (cylooxygenase-1) by valerylsalicylic acid. Arch. Biochem. Biophys. 317, 19–24.
Brannon, T. S., North, A. J., Wells, L. B., and Shaul, P. W. (1994). Prostacyclin synthesis in ovine pumonary artery is developmentally regulated by changes in cycloxygenase-1 gene expression. J. Clin. Invest. 93, 2230–2235.
Copeland, R. A., Williams, J. M., Giannaras, J., Nurnberg, S., Covington, M., PInto, D., Pick, S., and Trzaskos, J. M. (1994). Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc. Natl. Acad. Sci. USA 91, 11202–11206.
Crofford, L. J., Wilder, R. L., Ristimaki, A. P., Sano, H., Remmers, E. F., Epps, H. R., and Hla, T. (1994). Cyclooxygenase-1 and-2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J. Clin. Invest. 93, 1095–1101.
DeWitt, D. L., and Meade, E. A. (1993). Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Arch. Biochem. Biophys. 306, 94–102.
DeWitt, D. L., and Smith, W. L. (1988). Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc. Natl. Acad. Sci. USA 85, 1212–1416.
DeWitt, D. L., Day, J. S., Sonnenburg, W. K., and Smith, W. L. (1983). Concentrations of prostaglandin endoperoxide synthase and prostaglandin 12 synthase in the endothelium and smooth muscle of bovine aorta. J. Clin. Invest. 72, 1882–1888.
DeWitt, D. L., El-Harith, E. A., Kraemer, S. A., Andrews, M. J., Yao, E. F., Armstrong, R. L., and Smith, W. L. (1990). The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. J. Biol. Chem. 265, 5192–5198.
Evett, G. E., Xie, W., Chipman, J. G., Robertson, D. L., and Simmons, D. L. (1993). Prostaglandin G/H isoenzyme 2 expression in fibroblasts: regulation by dexamethasone, mitogens, and oncogenes. Arch. Biochem. Biophys. 306, 169–177.
Fletcher, B. S., Kujubu, D. A., Perrin, D. M., and Herschman, H. R. (1992). Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267, 4338–4344.
Funk, C. D., Funk, L. B., Kennedy, M. E., Pong, A. S., and Fitzgerald, G. A. (1991). Human plate-let/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 5, 2304–2312.
Futaki, N., Yoshikawa, K., Hamasaka, Y., Arai, I., Higuchi, S., Iizuka, H., and Otomo, S. (1993). NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24, 105–110.
Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., and Otomo, S. (1994). NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47, 55–59.
Gans, K. R., Galbraith, W., Roman, R. J., Haber, S. B., Kerr, J. S., Schmidt, W. K., Smith, C., Hewes, W. E., and Ackerman, N. R. (1990). Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor. J. Pharmacol. Exp. Ther. 254, 180–187.
Gierse, J. K., Hauser, S. D., Creely, D. P., Koboldt, C., Rangwala, S. H., Isakson, P. C., and Seibert, K. (1995). Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem. J. 305(15 Jan Pt 2), 479–484.
Han, J., Sadowski, H., Young, D. A., and Macara, I. G. (1990). Persistant induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 87, 3373–3377.
Hemler, M., Lands, W. E. M., and Smith, W. L. (1976). Purification of the cyclooxygenase that forms prostaglandins. Demonstration of two forms of iron in the holoenzyme. J. Biol. Chem. 251, 5575–5581.
Herschman, H. R. (1991). Primary response genes induced by growth factors and tumor promoters. In Annual Review of Biochemistry, vol. 60, C. C. Richardson, J. N. Abelson, A. Meister, and C. T. W. Walsh, eds. (Palo Alto: Annual Reviews Inc.), pp. 281–319.
Hla, T., and Neilson, K. (1992). Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA 89, 7384–7388.
Hoff, T., DeWitt, D., Kaever, V., Resch, K., and Goppelt-Struebe, M. (1993). Differentiation-associated expression of prostaglandin G/H synthase in monocytic cells. FEBS Lett. 320, 38–42.
Holtzman, M. J., Turk, J., and Shornick, L. P. (1992). Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells. J. Biol. Chem. 267, 21438–21445.
Hulkower, K. I., Wertheimer, S. J., Levin, W., Coffey, J. W., Anderson, C. M., Chen, T., DeWitt, D., Crowl, M., Hope, W. C., and Morgan, D. W. (1994a). Interleukin-1beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts: evidence for their roles in the production of prostaglandin E2. Arthritis Rheum. 37, 653–661.
Hulkower, K. I., Wertheimer, S. J., Levin, W., Coffey, J. W., Anderson, C. M., Chen, T., DeWitt, D. L., Crowl, R. M., Hope, W. C., and Morgan, D. W. (1994b). Interleukin-1 beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Evidence for their roles in the production of prostaglandin E2. Arthritis Rheum. 37, 653–661.
Jones, D. A., Carlton, D. P., McIntyre, T. M., Zimmerman, G. A., and Prescott, S. M. (1993). Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 268, 9049–9054.
Kargman, S., Chan, S., Evans, J., Vickers, P., and O’Neill, G. (1994). Tissue distribution of prostaglandin G/H synthase-1 and-2 (PGHS-1 and PGHS-2) using specific anti-peptide antibodies. J. Cell. Biochem. Supplement 18B, 319 (Abstract O109).
Kosaka, T., Miyata, A., Ihara, H., Hara, S., Takeda, O., Takahashi, E., and Tanabe, T. (1994). Characterization of the human gene (PTGS2) coding for prostaglandin endoperoxide synthase-2. Eur. J. Biochem., in press.
Kraemer, S. A., Meade, S. A., and DeWitt, D. L. (1992). Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5′-flanking regulatory sequences. Arch. Biochem. Biophys. 293, 391–400.
Kudo, I., Murakami, M., Hara, S., and Inoue, K. (1993). Mammalian non-pancreatic phospholipases A2. Biochim. Biophys. Acta 1170, 217–231.
Kujubu, D. A., and Herschman, H. R. (1992a). Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J. Biol. Chem. 267, 7991–7994.
Kujubu, D. A., and Herschman, H. R. (1992b). Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J. Biol. Chem. 267, 7991–7994.
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., and Herschman, H. R. (1991). TIS10, a phorbol ester tumor promoter inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266, 12866–12872.
Kujubu, D. A., Reddy, S. T., Fletcher, B. S., and Herschman, H. R. (1993). Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. J. Biol. Chem. 268, 5425–5430.
Kulmacz, R. J. (1989). Topography of prostaglandin H synthase. Antiinflammatory agents and the protease-sensitive arginine 253 region. J. Biol. Chem. 264, 14136–14144.
Laneuville, O., Breuer, D. K., DeWitt, D. L., Hla, T., Funk, C. D., and Smith, W. L. (1994). Differential inhibition of human prostaglandin endoperoxide H synthases-1 and-2 by nonsteroidal anti-inflammatory drugs. J. Pharm. Exp. Therap. 271, 927–934.
Laneuville, O. I., Breuer, D. K., Xu, N., Huang, Z. H., Gage, D. A., Watson, J. T., Lagarde, M., DeWitt, D. L., and Smith, W. L. (1995). Fatty acid substrate specificities of hyuman prostaglandin H synthases-1 and-2: Formation of 12 hydroxy-(9Z,13E/Z,15Z)-Octadecatrienoic acids from alpha-linolenic acid. J. Biol. Chem., in press.
Lecomte, M., Laneuville, O., Ji, C., DeWitt, D. L., and Smith, W. L. (1994). Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J. Biol. Chem. 269, 13207–13215.
Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., and Hwang, D. (1992). Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267, 25934–25938.
Mancini, J. A., O’Neill, G. P., Bayly, C., and Vickers, P. J. (1994). Mutation of serine-516 in human prostaglandin G/H synthase-2 to methionine or aspirin acetylation of this residue stimulates 15-R-HETE synthesis. FEBS Lett. 342, 33–37.
Marshall, P. J., and Kulmacz, R. J. (1988). Prostaglandin H synthase: distinct binding sites for cyclooxygenase and peroxidase substrates. Arch. Biochem. Biophys. 266, 162–170.
Meade, E. A., Smith, W. L., and DeWitt, D. L. (1993a). Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268, 6610–6614.
Meade, E. A., Smith, W L., and DeWitt, D. L. (1993b). Expression of the murine prostaglandin (PGH) synthase-1 and PGH synthase-2 isozymes in cos-1 cells. J. Lipid Mediators 6, 119–129. (this is the reference describing the subcloning of the pghs1 and pghs2 into cos cell expression vectors)
Merlie, J. P., Fagan, D., Mudd, J., and Needleman, P. (1988). Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J. Biol. Chem. 263, 3550–3553.
Mertz, P. M., DeWitt, D. L., Stetler-Stevenson, W. G., and Wahl, L. M. (1994). Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J. Biol. Chem. 269, 21322–21329.
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., and Vane, J. R. (1993). Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U. S. A. 90, 11693–11697.
Miyamoto, T., Ogino, N., Yamamoto, S., and Hayaishi, O. (1976). Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem. 251, 2629–2636.
Mizuno, K., Yamamoto, S., and Lands, W. E. M. (1982). Effects of non-steroidal anti-inflammatory drugs on fatty acid cyclooxygenase and prostaglandin hydroperoxidase activities. Prostaglandins 23, 743–757.
Morita, I., Schindler, M., Regier, M. K., Otto, J. C., Hori, T., DeWitt, D. L., and Smith, W. L. (1994). Different intracellular locations for prostaglandin endoperoxide H synthatses-1 and-2. J. Biol. Chem. in press.
Murakami, M., Matsumoto, R., Austen, K. F., and Arm, J. P. (1994). Prostaglandin endoperoxide synthase-1 and-2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells. J. Biol. Chem. 269, 22269–22275.
O’Banion, M. K., Winn, V. D., and Young, D. A. (1992). cDNA Cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA 89, 4888–4892. (induction with interleukin 1B in fibroblasts and monocytes)
Ohki, S., Ogino, N., Yamamoto, S., and Hayaishi, O. (1979). Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem. 254, 829–836.
O’Neill, G. P., and Ford-Hutchinson, A. W. (1993). Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330, 156–160.
O’Neill, G. P., Mancini, J. A., Kargman, S., Yergey, J., Kwan, M. Y., Falgueyret, J. P., Abramovitz, M., Kennedy, B. P., Ouellet, M., Cromlish, W., et al. (1994). Overexpression of human prostaglandin G/H synthase-1 and-2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol. Pharmacol. 45, 245–254.
O’Sullivan, G. M., Chilton, F. H., Huggins Jr., E. M., and McCall, C. E. (1992). Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J. Biol. Chem. 267, 14547–14550.
O’Sullivan, M. G., Huggins Jr., E. M., Meade, E. A., DeWitt, D. L., and McCall, C. E. (1992). Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem. Biophys. Res. Commun. 187, 1123–1127.
Otto, J. C., and Smith, W. L. (1994). The orientation of prostaglandin endoperoxide synthases-1 and-2 in the endoplasmic reticulum. J. Biol. Chem. 269, 19868–19875.
Otto, J. C., DeWitt, D. L., and Smith, W. L. (1993). N-glycosylation of prostaglandin endoperoxide synthases-1 and-2 and their orientations in the endoplasmic reticulum. J. Biol. Chem. 268, 18234–18242.
Percival, M. D., Oullet, M., Vincent, C. J., Yergey, J. A., Kennedy, B. P., and O’Neill, G. P. (1994). Purification and characterization of recombinant hman cylooxygenase-2. Arch. Biochem. Biophys. 315, 111–118.
Picot, D., and Garavito, R. M. (1994). Prostaglandin H synthase: implications for membrane structure. FEBS Lett. 346, 21–25.
Picot, D., Loll, P. J., and Garavito, M. (1994). The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature 367, 243–249.
Pilbeam, C. C., Kawaguchi, H., Hakeda, Y., Vosnesensky, O., Alander, C. B., and Raisz, L. G. (1993). Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J. Biol. Chem. 268, 25643–25649.
Prasit, P. L-745,337, a selective COX-2 inhibitor. Presented at the Annual Meeting of American Chemical Society. August 25, 1994, Washington D.C.
Raz, A., Wyche, A., Siegel, N., and Needleman, P. (1988). Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J. Biol. Chem. 263, 3022–3028.
Reddy, S. T., and Herschman, H. R. (1994). Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J. Biol. Chem. 269, 15473–15480.
Regier, M. K., DeWitt, D. L., Schindler, M. S., and Smith, W. L. (1993). Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 3T3 cells. Arch. Biochem. Biophys. 301, 439–444.
Riese, J., Hoff, T., Nordhoff, A., DeWitt, D. L., Resch, K., and Kaever, V. (1994). Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J. Leukoc. Biol. 55, 476–482.
Ristimaki, A., Garfinkel, S., Wessendorf, J., Maciag, T., and Hla, T. (1994). Induction of cylooxygenase-2 by interleukin-1 alpha: evidence for post-transcriptional regulation. J. Biol. Chem. 269, 11769–11777.
Rome, L. H., and Lands, W. E. M. (1975). Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs. Proc. Natl. Acad. Sci. USA 72, 4863–4865.
Roshak, A., Sathe, G., and Marshall, L. A. (1994). Suppression of monocyte 85-kDa phospholipase A2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis. J. Biol. Chem. 269, 25999–26005.
Sano, H., Hla, T., Maier, J. A. M., Crofford, L. J., Case, J. P., Maciag, T., and Wilder, R. L. (1992). In vivo cyclooxygenase expression in synovial tissue of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J. Clin. Invest. 89, 97–108.
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., and Isakson, P. (1994). Pharmacological and biochemical demonstration of the role of cylooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA 91, 12013–12017.
Shaw, G., and Kamen, R. (1986). A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective degradation. Cell 46, 659–667.
Shimokawa, T., and Smith, W. L. (1991). Essential histidines of prostaglandin endoperoxide synthase. J. Biol. Chem. 266, 6168–6173.
Shimokawa, T., and Smith, W. L. (1992). Prostaglandin endoperoxide synthase: The aspirin acetylation region. J. Biol. Chem. 267, 12387–12392.
Simmons, D. L., Xie, W., Chipman, J. G., and Evett, G. E. (1991). Multiple cyclooxygenases: cloning of a mitogen-inducible form. In Prostaglandins, Leukotrienes, Lipoxins, and PAF, J. M. Bailey, ed. (New York: Plenum Press), pp. 67–78.
Sirois, J., and Richards, J. S. (1992). Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles. J. Biol. Chem. 267, 6382–6388.
Smith, C. J., Morrow, J. D., Roberts, L. J., and Marnett, L. J. (1993). Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (Cox-1). Biochem. Biophys. Res. Commun. 192, 787–793.
Smith, W. L., and DeWitt, D. L. (1995). Cyclooxygenases. In Lipobiology, R. W Gross, ed. (: Raven Press).
Smith, W. L., and Lands, W E. (1971). Stimulation and blockade of prostaglandin biosynthesis. J. Biol. Chem. 246, 6700–6702.
Toh, H. (1989). Prostaglandin endoperoxide synthase contains an EGF-like domain. FEBS Lett. 258, 317–319.
Van der Ouderaa, F. J., Buytenhek, M., Nugteren, D. H., and Van-Dorp, D. A. (1980). Acetylation of prostaglandin endoperoxide synthetase with acetylsalicylic acid. Eur. J. Biochem. 109, 1–8.
Vane, J. R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. New. Biol. 231, 232–235.
Wilborn, J., DeWitt, D. L., and Peters-Golden, M. (1995). Expression oand role cyclooxygenase isoforms in alveolar and peritoneal macrophages. American Journal of Physiology: Lung, Cellular and Molecular Physiology, in press.
Xie, W., Chipman, J. G., Robertson, D. L., Erikson, R. L., and Simmons, D. L. (1991). Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA 88, 2692–2696.
Yamagata, K., Andreasson, K. I., Kaufmann, W. E., Barnes, C. A., and Worley, P. F. (1993). Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11, 371–386.
Yokoyama, C., and Tanabe, T. (1989). Cloning of the human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem. Biophys. Res. Commun. 165, 888–894.
Yokoyama, C., Takai, T., and Tanabe, T. (1988). Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence. FEBS Lett. 231, 347–351.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
DeWitt, D.L. (1996). The Physiological and Therapeutic Significance of Separate Pathways for Prostaglandin Synthesis. In: Folco, G.C., Samuelsson, B., Maclouf, J., Velo, G.P. (eds) Eicosanoids. NATO ASI Series, vol 283. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0200-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0200-9_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0202-3
Online ISBN: 978-1-4899-0200-9
eBook Packages: Springer Book Archive